12-57243821-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_145064.3(STAC3):c.1086G>A(p.Glu362=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0022 in 1,614,008 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 32 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 41 hom. )
Consequence
STAC3
NM_145064.3 synonymous
NM_145064.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.37
Genes affected
STAC3 (HGNC:28423): (SH3 and cysteine rich domain 3) The protein encoded by this gene is a component of the excitation-contraction coupling machinery of muscles. This protein is a member of the Stac gene family and contains an N-terminal cysteine-rich domain and two SH3 domains. Mutations in this gene are a cause of Native American myopathy. [provided by RefSeq, Nov 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 12-57243821-C-T is Benign according to our data. Variant chr12-57243821-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 262571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.37 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0117 (1788/152330) while in subpopulation AFR AF= 0.0404 (1681/41574). AF 95% confidence interval is 0.0388. There are 32 homozygotes in gnomad4. There are 844 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 32 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAC3 | NM_145064.3 | c.1086G>A | p.Glu362= | synonymous_variant | 12/12 | ENST00000332782.7 | NP_659501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAC3 | ENST00000332782.7 | c.1086G>A | p.Glu362= | synonymous_variant | 12/12 | 2 | NM_145064.3 | ENSP00000329200 | P1 | |
STAC3 | ENST00000554578.5 | c.969G>A | p.Glu323= | synonymous_variant | 11/11 | 1 | ENSP00000452068 | |||
STAC3 | ENST00000557176.5 | c.*146G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 1 | ENSP00000450740 | ||||
STAC3 | ENST00000546246.2 | c.528G>A | p.Glu176= | synonymous_variant | 9/9 | 2 | ENSP00000441515 |
Frequencies
GnomAD3 genomes AF: 0.0117 AC: 1783AN: 152212Hom.: 32 Cov.: 32
GnomAD3 genomes
AF:
AC:
1783
AN:
152212
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00301 AC: 754AN: 250542Hom.: 17 AF XY: 0.00211 AC XY: 286AN XY: 135660
GnomAD3 exomes
AF:
AC:
754
AN:
250542
Hom.:
AF XY:
AC XY:
286
AN XY:
135660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00120 AC: 1760AN: 1461678Hom.: 41 Cov.: 32 AF XY: 0.00103 AC XY: 747AN XY: 727122
GnomAD4 exome
AF:
AC:
1760
AN:
1461678
Hom.:
Cov.:
32
AF XY:
AC XY:
747
AN XY:
727122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0117 AC: 1788AN: 152330Hom.: 32 Cov.: 32 AF XY: 0.0113 AC XY: 844AN XY: 74484
GnomAD4 genome
AF:
AC:
1788
AN:
152330
Hom.:
Cov.:
32
AF XY:
AC XY:
844
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 29, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Bailey-Bloch congenital myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at